Assyro AI

Orange Book product · Brand (NDA)

TRAVATAN Z

TRAVOPROST

Brand (NDA)NDA 021994TE AT2RX SANDOZ

At a glance

Sep 21, 2006

Approved

Brand (NDA)

Application

AT2

TE code

3

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Sep 21, 2006

    20 yr ago

  2. Today

  3. Patent 8323630 expires

    Listed drug product patent expiration.

    Sep 20, 2027

    in 1 yr 3 mo

  4. Patent 8388941 expires

    Listed drug product patent expiration.

    Sep 20, 2027

    in 1 yr 3 mo

  5. Patent 8268299 expires

    Listed drug product patent expiration.

    Oct 13, 2029

    in 3 yr 4 mo

Pharmaceutical detail

Active ingredient

TRAVOPROST

Strength

0.004%

Dosage form

SOLUTION/DROPS

Route

OPHTHALMIC

TE code

AT2

Application

NDA 021994

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (3)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8323630Sep 20, 2027in 1 yr 3 mo
Product
8388941Sep 20, 2027in 1 yr 3 mo
Product
8268299Oct 13, 2029in 3 yr 4 mo
Product
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.